Genpact Ltd.

Genpact has reached a new 52-week low, with a significant one-year performance decline. Despite this, the company maintains a strong market capitalization and management efficiency, evidenced by a high return on equity and low debt-to-equity ratio. Its operating profit growth and cash flow highlight resilience amid challenging market conditions.

Genpact has reached a new 52-week low, trading at USD 27.40, reflecting a notable decline over the past year. Despite this, the company maintains a market capitalization of USD 6,250 million, strong management efficiency, and a commitment to shareholder value through dividends and operating profit growth.

Genpact has reached a new 52-week low, trading at USD 33.15. Despite a modest annual return of 5.69%, the company maintains a market capitalization of USD 6,540 million, strong management efficiency, and a low debt-to-equity ratio. Its financial metrics indicate a stable foundation for potential recovery.

Genpact has reached a new 52-week low, trading at USD 33.54, reflecting a notable decline for the small-cap company. Despite this, it maintains a low price-to-earnings ratio and strong financial metrics, including a solid return on equity and low debt-to-equity ratio, indicating potential for long-term growth.

Genpact has reached a new 52-week low of USD 33.67, reflecting a notable decline despite a modest annual return of 2.89%. The company, with a market cap of USD 6,540 million, demonstrates strong management efficiency and low leverage, alongside healthy long-term growth and a high dividend yield.

Genpact has hit a new 52-week low, trading at USD 33.74, reflecting a notable decline for the small-cap company. Despite a modest annual return of 4.38%, it maintains a strong P/E ratio of 12.00, a solid return on equity of 22.31%, and a low debt-to-equity ratio of 0.15.

Genpact Ltd. has recently encountered a Death Cross, indicating a potential shift in market sentiment. Technical indicators suggest a bearish outlook, yet the stock has shown resilience with a slight daily increase. Over the past year, Genpact has struggled, significantly underperforming compared to the S&P 500.

Genpact Ltd. has recently revised its evaluation amid challenging market conditions, with its stock price showing a slight increase. Over the past year, the company has experienced a significant decline, contrasting with broader market gains. Technical indicators present a mixed outlook, reflecting ongoing market indecision.

Genpact Ltd. saw a notable rise in its stock price on November 7, 2025, reaching an intraday high. The company has demonstrated strong short-term performance, although it has underperformed compared to the S&P 500 over the past year. Genpact maintains solid financial metrics, including high management efficiency and low debt levels.

Genpact has hit a new 52-week low of USD 37.50, reflecting a notable decline in its performance compared to the S&P 500. The company, with a market cap of USD 7,759 million, shows a low debt-to-equity ratio and high management efficiency, but its net profit has decreased significantly.

Genpact has reached a new 52-week low, trading at USD 37.77, reflecting a notable decline for the small-cap company. Despite a low debt-to-equity ratio and strong management efficiency, its net profit has decreased significantly. The stock is trading at a discount compared to historical valuations.

Genpact Ltd. has recently adjusted its valuation, with its stock price at $39.44. Over the past year, it has achieved a 2.49% return, lagging behind the S&P 500. Key metrics include a P/E ratio of 14, an EV to EBITDA ratio of 10.29, and a notable dividend yield of 150.00%.

Genpact Ltd. has recently adjusted its technical trends, with its current price slightly lower than the previous close. Over the past year, the company has underperformed compared to the S&P 500. Various technical indicators suggest a predominantly bearish outlook, reflecting ongoing challenges in the market.